|
Verteporfin Clinical Trials
4 actively recruiting trials across 4 locations
Also known as: BPD-MA, Benzoporphyrin Derivative Monoacid Ring A, Visudyne
Pipeline
Phase 2: 1Phase 1/2: 3
Top Sponsors
- SpectraCure AB1
- Roswell Park Cancer Institute1
- Mayo Clinic1
- Emory University1
Indications
- Cancer4
- Unresectable Pancreatic Adenocarcinoma1
- Metastatic Pancreatic Adenocarcinoma1
- Stage II Pancreatic Cancer AJCC v81
- Locally Advanced Pancreatic Adenocarcinoma1
Atlanta, Georgia1 trial
Verteporfin for the Treatment of Recurrent High Grade EGFR-Mutated Glioblastoma
Emory University Hospital/Winship Cancer Institute
Phase 1/2
Rochester, Minnesota1 trial
Buffalo, New York1 trial
Interstitial Photodynamic Therapy Following Palliative Radiotherapy in Treating Patients With Inoperable Malignant Central Airway Obstruction
Roswell Park Cancer Institute
Phase 1/2
New York, New York1 trial
Clinical Study to Assess the Safety and Efficacy of the SpectraCure P18 System
Memorial Sloan Kettering Cancer Center
Phase 1/2
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.